Not recruiting
Glioblastoma
Not recruitingStudy of AGuIX Nanoparticles and Temozolomide with Radiotherapy for Patients with Newly Diagnosed Glioblastoma
InvestigationalNo placebo
Study of AGuIX Nanoparticles and Temozolomide with Radiotherapy for Patients with Newly Diagnosed Glioblastoma
InvestigationalNo placebo
- Disease:Glioblastoma
- Substances:Gadolinium-chelated polysiloxane nanoparticles
Countries:
France
France- Participants:18–64 years · 65+ years
- Substances:Gadolinium-chelated polysiloxane nanoparticles
